Should you worry about A2 MILK FPO NZ and Bellamy's Australia Ltd crashing?

The share prices of Bellamy's Australia Ltd (ASX:BAL) and A2 MILK FPO NZ (ASX:A2M) suffered a hard landing on Wednesday.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of A2 MILK FPO NZ (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL) begun yesterday in the same way they've spent most of 2015. Both shares soared, each touching new all-time highs and giving shareholders yet another reason to smile going into the New Year.

But then something out of the ordinary happened: both companies' shares fell, hard.

The A2 Milk share price soared as much as 9.8% to a new high of $2.36, but ended the day 12.8% lower than its previous close at just $1.875. Similarly, Bellamy's share price peaked at $16.50 (after debuting on the ASX at just $1 per share in August 2014), but ended the session 9.4% lower than its previous closing price at $14.02.

A2 Milk is down another 6.1% early in today's session, while Bellamy's shares have fallen 5.1% to $13.30.

What does this mean?

The 2015 calendar year has been a bumper year for essentially anything milk or baby-related, especially thanks to the red-hot demand from countries such as China. A2 Milk and Bellamy's have been the most notable beneficiaries but shares of Bega Cheese Ltd (ASX: BGA), Blackmores Limited (ASX: BKL), Baby Bunting Group Ltd (ASX: BBN) and, more recently, Australian Dairy Farms Group (ASX: AHF), have also rocketed in price.

The returns have been truly incredible for shareholders – especially those who bought in early – but it has also led to speculation that shares may have become overpriced. The sudden plunge in A2 Milk's and Bellamy's share prices yesterday and this morning will no doubt have some investors feeling anxious about what happens next.

What happens next?

Unlike some of the speculative tech stocks of the past which have soared for no apparent reason, there is a legitimate reason behind A2 Milk's and Bellamy's spectacular returns. Demand for their products has skyrocketed – so much so that they have struggled to keep supermarket shelves stocked – which has led to surging sales and profits.

A2 Milk, for instance, upgraded its EBITDA (earnings before interest, tax, depreciation and amortisation) guidance for the 2016 financial year from $12 million to $22 million in November, and then from $22 million to roughly $35 million a week before Christmas – a total guidance increase of 192% in just over a month.

Meanwhile, Bellamy's is expected to announce another bumper result when it reports its half-year earnings in February after it reported a 617% increase in net profit after tax (NPAT) for the 2015 financial year.

The incredible share price gains for both companies indicate that they are well and truly on the radar of investors by now, and the early profits have clearly already been made.

In other words, the shares are by no means 'cheap' anymore, at least not by conventional standards. But yesterday's sharp pull-back in price doesn't necessarily mean their strong run is over, either, especially if they can keep boosting supplies and growing their earnings.

For the sake of full disclosure, I'll note that I recently reduced my stake in Bellamy's based on the fact that it had skyrocketed in price and become, in my opinion, an overly large position in my own portfolio, but I am still holding a decent amount of shares. If the shares pull back much more, they could certainly be worth a closer look for investors.

Motley Fool contributor Ryan Newman owns shares of Bellamy's Australia. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »